Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 335 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

SOUTH ASIAN GUIDELINES FOR MANAGEMENT OF ENDOCRINE DISORDERS IN RAMADAN

South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during Ramadan

Pathan Md Faruque, Sahay Rakesh Kumar, Zargar Abdul Hamid, Raza Syed Abbas, Azad Khan A K, Siddiqui Nazrul Islam, Amin Firoz, Kalra Sanjay

Year : 2012| Volume: 16| Issue : 4 | Page no: 525-527

   This article has been cited by
 
1 Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial Evidence
Saud Al Sifri,Kashif Rizvi
Diabetes Therapy. 2016;
[Pubmed]  [Google Scholar] [DOI]
2 Ramadan and diabetes: What we see, learn and understand from continuous glucose monitoring
L. Monnier,A. El Azrak,N. Lessan,D. Rochd,C. Colette,F. Bonnet
Diabetes & Metabolism. 2015; 41(6): 456
[Pubmed]  [Google Scholar] [DOI]
3 A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial
E. M. Brady,M. J. Davies,L. J. Gray,M. A. Saeed,D. Smith,W. Hanif,K. Khunti
Diabetes, Obesity and Metabolism. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
4 Diabète et Ramadan: Mise au point sur les recommandations récentes
S. El Aziz,S. Skalli,A. Chadli,H. El Ghomari,A. Farouqi
Médecine des Maladies Métaboliques. 2014; 8(2): 221
[Pubmed]  [Google Scholar] [DOI]

 

Read this article